3American Diabetes Association. Standards of medical care in diabetes-2011[J].{H}DIABETES CARE,2011,(05):S11-S60.
4Nathan DM,Buse JB,Davidson MB. Medical management of hyperglycaemia in type 2 diabetes mellitus:A consensus algorithm for the initiation and adjnstment of therapy:a consensus statement from the American diabetes association and the European Association for the study of diabetes[J].Diabetolgia,2009,(01):17-30.
5杨文英.中国2型糖尿病防治指南[M]{H}北京:北京大学医学出版社,201021.
6McAlister FA,Majumdar SR,Eurich DT. The effect of specialist care within the first year on subsequent outcomes in 24 232 adults with new-onset diabetes mellitus:population-based cohort study[J].{H}QUALITY AND SAFETY IN HEALTH CARE,2007,(01):6-11.
7Salpeter SR,Greyber E,Pasternak GA. Risk of fatal and nonfatal lactic acidosis with meformin use in type 2 diabetes mellitus[J].{H}Cochrane Database of Systematic Reviews,2006,(01):CD002967.
8Salpeter SR,Greyber E,Pasternak GA. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus[J].{H}Cochrane Database of Systematic Reviews,2010,(04):CD002967.
9Bodmer M,Meier C,Krahenbuhl S. Metformin,sulfonylureas,or other anti-diabêtes drugs and the risk of lactic acidosis or hypoglycemia:a nested case-control analysis[J].{H}DIABETES CARE,2008,(11):2086-2091.
10Bolen S,Feldman L,Vassy J. Systematic review:comparative effectivene and safety of oral medications for type 2 diabetes mellitus[J].{H}ANNALS OF INTERNAL MEDICINE,2007,(06):386-399.
